CNS lymphoma · 4 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Ifosfamide and Methotrexate Variant #01 | — | R 10 227 | — | — | — | ~8 | ~R 81 814 indirect | — |
Cytarabine and Etoposide (CYVE) Variant #06 | — | R 4 351 | — | — | ~9.2 mo | ~2 | ~R 8 701 PFS proxy · indirect | — |
High-dose Cytarabine monotherapy (HiDAC) Variant #01 | — | R 3 498 | — | ~5.2 mo | — | ~1 | ~R 3 498 PFS proxy · indirect | 1 |
Whole brain irradiation N/A - radiation | — | — | 21d | — | — | — | — | 1 |
4 of 4 regimens shown